Leukemia News - ScienceDaily
4 days ago · Read the latest medical research and information on leukemia. Learn about the symptoms and diagnosis of chronic myeloid leukemia (CML) and other leukemia types. What …
FDA Approves New Drug for the Most Common Form of Leukemia …
Rye Brook, N.Y., December 8, 2023 – The U.S. Food and Drug Administration has approved pirtobrutinib (Jaypirca™) for the treatment of adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has worsened or returned despite at least two earlier forms of treatment.
Advances in Leukemia Research - NCI - National Cancer Institute
Find out what's new in current leukemia research including progress on targeted therapies and immunotherapies, and NCI programs and clinical trials.
Blood Cancer News | Leukemia and Lymphoma Society
Our team of experts bringing you blood cancer-related news and updates. The U.S. Food and Drug Administration yesterday approved nelarabine injection, a critical treatment for T-cell acute lymphoblastic leukemia (T-ALL), an aggressive blood cancer that is most common in children.
FDA Approves First of a New Class of Drugs to Treat Advanced Acute Leukemia
Rye Brook, N.Y., December 6, 2024 – The U.S. Food and Drug Administration (FDA) has approved revumenib (Revuforj®), a first-of-its-kind treatment for adults and children aged 1 year and older with advanced acute myeloid leukemia (AML). It is approved for use in patients with a specific mutation called a KMT2A gene translocation.
Mitochondrial DNA plays an underappreciated role in leukemia ...
6 days ago · Leukemia thrives in mtDNA mutation ‘sweet spot’ Introducing individual mutations to mtDNA is challenging due to the large number of mitochondria within each cell. Instead, the researchers used a leukemia mouse model with a defective genetic proofreading system called Polg, which gradually accrues mtDNA mutations.
Leukemia - latest research news and features - Medical Xpress
Find all the latest on leukemia at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.
New triplet therapies show promise for relapsed and newly …
Dec 9, 2024 · In November, the Food and Drug Administration approved revumenib as a single-agent therapy for the treatment of adults and pediatric patients with relapsed or refractory advanced acute leukemia...
New Drug Dramatically Improves Survival for Children with …
Dec 9, 2024 · Blinatumomab is an antibody drug with two “arms” – one arm recognizes leukemia cells, and the other recognizes T cells, which are immune cells that protect the body from disease. The drug essentially pulls both arms together so the T …
First-in-Class Leukemia Treatment Approved by FDA - WebMD
Nov 19, 2024 · The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.